The sheets in this spreadsheet displays all of our results, including a summary table of our main findings, all sensitivity analyses (different MR methods, sensitivity analyses relating to cis-SNP effects of all blood markers, sensitivity analyses relating to the association between significant blood markers and BMI, sensitivity analyses relating to the genetic instruments used in our analyses), the lists of the associations between both COVID phenotypes and all blood markers, in both directions, as well the full details of all SNP instruments used for the association with significant blood markers. by Alish B. Palmos (5857379)

Kaplan–Meier curves for all-cause mortality. by Arisa Kobayashi (4379608)

Subjects:

Associations between BCG treated and their controls to be diagnosed with AD or dementia in different subgroups and in all categories. by Eugen Wang (17636322)

Subjects:

Demographic and clinicopathological characteristics of all included patients. by Na Li (6550)

Subjects:

Kaplan–Meier curves for all-cause mortality between two propensity score-matched groups. by Arisa Kobayashi (4379608)

Subjects:

All significant factors across the different analyses. by Amy Mitchell (3208905)

Crude incidence rates of stroke and all-cause mortality. by Simon de Lusignan (2416)

Subjects:

Unadjusted cumulative incidence of stroke and all-cause mortality. by Simon de Lusignan (2416)

Subjects:

The complexes that are significantly identified by all three maps and the significance level for each in different maps. by Safiye Celik (3491204)

Unadjusted cumulative incidence of stroke and all-cause mortality by type of anti-coagulant. by Simon de Lusignan (2416)

Subjects:

SLE decreases risk for hormonal cancers. by Deborah K. Johnson (10001156)

“…(a) Breast cancer incidence in female SLE cohort is significantly decreased by SLE status (OR 0.52, 95% CI 0.35, 0.74, p = 0.0036). …”

Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. by Mieke L. M. Bentvelzen (21594442)

Contributing factors for cardio-cerebrovascular complications in all subjects including immigrants and native-born Korean with diabetes. by Hyemin Cho (1821676)

Subjects:

Time-varying effect of anti-coagulation regime on sub-distribution hazards for all-cause mortality. by Simon de Lusignan (2416)

Subjects:

Baseline characteristics of study cohort (n, %) showing the probability of any differences between event free, stroke and all-cause mortality groups between those exposed to Warfar... by Simon de Lusignan (2416)

Subjects:

Spearman correlations between the age of the sample donor (20–70 years) and estimated proportions of neuronal, glial, and endothelial cells. by Arttu Autio-Kimura (20454681)

Subjects:

Box plots for subsets of male originating samples, displaying the distributions of the proportions of neuronal, glial, and endothelial cells. by Arttu Autio-Kimura (20454681)

Subjects:

Bootstrapped spearman correlations from a randomly selected subset of male sample donor originating samples (n = 493). by Arttu Autio-Kimura (20454681)

Subjects:

Schematic summary of statistically significant sex differences in all measured endpoints of this study. by Sergio E. Chiarella (169566)

Multivariate analysis of the cause-specific hazard ratio (CSHR) for all-cause mortality, interpreted as time-averaged effects. by Simon de Lusignan (2416)

Subjects: